In the early stage of drug development, the process of screening and characterizing compounds that interact with cellular and protein targets is essential. Creative Biostructure provides MagHelix™ Quartz Crystal Microbalance-Dissipation (QCM-D) solutions for drug discovery departments in the pharmaceutical industry and biotechnology companies to detect the activity of compounds on specific biological macromolecular targets or whole cells. QCM-D technology ensures that the detection process is carried out in a high speed, small sample quantities, real-time and economical way. Our QCM-D services detect the kinetics and magnitude of a cell, membrane, and protein drug targets response with respect to ligand binding, providing a wealth of information for effective drug screening.